Hepatoprotective Activity of Oxalis corniculata Leaves against Carbon
Tetrachloride Induced Hepatotoxicity in Female Albino
Wistar Rats
Jadhav Anil G*1, Patil Mrutyunjay B1,
Narkhede Sachin B2
and G Vidya
Sagar3
1 KLES College of
Pharmacy, Belgaum, Karnataka, India.
2 Smt.BNB Swaminarayan Pharmacy College,Salvav (Vapi).
3Dean,Veerayatan
institute of pharmacy,kutch-370 460,gujarat
ABSTRACT:
In recent times lot of
interest has been generated to find out a natural remedy for hepatic disorders
caused by toxins like alcohol and hepatitis virus. The present study is designed and investigate the hepatoprotective activity of Oxalis
corniculata leaves against carbon
tetrachloride (CCl4) induced hepatotoxicity
in female Albino Wistar rats. Forty two Albino Wistar female rats were divided in to seven equal groups
each containing six animals. Four groups received the extracts of Oxalis corniculata leaves and intraperitoneal (i.p.) CCl4 (2
ml/kg) with administration of extracts. One group was control, one treated with
CCl4 and one with normal saline. The hepatotoxicity
was assessing by plasma concentration of serum bilirubin
and enzymes activities. The aqueous extract (500mg/kg b.w)
of Oxalis corniculata significantly reduced carbon
tetrachloride induce damages in the liver which is measured by SGOT, SGPT, SALP
and serum bilirubin levels in blood. The attempt has
been made to extract the active constituent and identified by phytochemical investigation and hepatoprotective
activity of leaves of Oxalis corniculata.
KEYWORDS: Oxalis corniculata, carbon tetrachloride, hepatoprotective.
INTRODUCTION:
Oxalis corniculata Linn. Family Oxalidaceae1
It is a diffuse annual or perennial, procumbent or more or the less erect
acidic herb, 6 – 25 cms high.2, 3 It is
found mostly in all the regions throughout the warmer parts of India, Sri Lanka
and other countries.4 Growing in various regions up to altitude of
nearly 8000 ft. in Himalaya. It occurs as a common herb specially
in shaded localities, ravines, river banks, warm margins, gardens, fields,
roadsides, forest edges and scrub jungles, ground patches.5
Leaves palmately 3-foliolate;
petioles 3.8 – 9 cm long very slender, pubescent; stipules small, oblong, adnate to the petiole; leaflets 1.2 to 2.5 cm. long, abcordate, cuneate at base, subsessile, glabrous or with a few appressed
hairs and with ciliate margins. 6
The
leaves of Oxalis corniculata
Linn.
are used in scurvy, fever, inflammation7, pain, indigestion, warts,
corns, dyspepsia, bilious headache,8 heart disease, piles,
haemorrhage,5 also useful in anaemia, tympanitis, inflamed ulcers, cephalagia,
dysmenorrhoea, amenorrhoea,
hepatopathy and also in Datura
poisoning as antidote.9 Leaves acts as diuretic febrifuge,
antibacterial, vermifuge, emmenagogue,
antiseptic,8 refrigerant,5 antiscorbutic.10
The paste of top shoots along with a few fruits of black pepper is applied to
boils, abscess, wound and weeping eczema.10 In unani
formulation (Kushta Tamysar)
Oxalis corniculata
Linn it is used as stomachic, liver tonic, aphrodisiac and used in paralysis,
facial paralysis, rheumatism, gout and catarrh.11
Methanol extract of Oxalis corniculata
reported that relaxant activity on isolated rabbit ileum which was dose
dependent and also showed cardio relaxant activity on isolated rabbit hear.12Water extracts of Oxalis corniculata showed
antifungal activity. 13 It is also reported to be used in oral health care.14
MATERIAL
AND METHOD:
Plant
Material
Procurement
of drugs: The Oxalis corniculata leaves were collected
from Dharwad district of Karnataka in southern India.
Authentication:
Oxalis
corniculata Linn. Oxalidaceae
were authenticated at s SSVPS science
college, Dhule (Maharastra)
by Dr. D. A. Patil.
Drying
and size reduction: In
the present study, Oxalis corniculata leaves
was reduced to coarse powder (# 40
size mesh) using mechanical grinder.
Extraction:
The
powdered material was subjected for extraction by maceration by chloroform
water and continuous hot extraction by petroleum ether (40- 60oC),
chloroform and alcohol. After the complete extraction, the solvents were
distilled off and concentrated on a water bath to get a dry residue. Some part
of the total extracts was reserved for phytochemical
investigation and assessment of hepatoprotective
activity.
Phytochemical
screening: Identification
of chemical constituents was carried out on the same extracts used in
pharmacological tests according to the methodology15.
Materials
used: CCl4 was obtained from Sigma-Aldrich. All
other chemicals used were of analytical grade.
Assessment
of Hepatoprotective activity:
Animal selection: Female Albino Wistar strain rats weighing between 120-150 gm were used
for hepatoprotective model. Rats were kept in
polypropylene cages and led on standard diet and water. The registration number
of animal ethical committee is CPCSEA 221 resolution No.12. The animals were
exposed to 12 hours of darkness and light each.
The bedding materials of cages were changed everyday.
Rats were divided into groups of six.
LD50 study It was carried out
by administering large doses of extracts from 500 mg/Kg to 5000 mg/Kg. At the
dose of 5000 mg/Kg half the population of animals was found to be dead for
every extract. Thus, this dose was considered as LD50. Therefore the
dose 500 mg/kg was used in this study.
The
method according to Handa SS and Sharma A16
has been used in this study. The above extracts were administered on group of 6
female albino Wistar rats, weighing about 120-150g,
for recording enzymatic levels and histopathology during the evaluation. Animals were administered with carbon
tetrachloride (2 ml/kg) i.p. to induce hepatotoxicity.
Marked increased in the serum level or SGOT, SGPT, SALP, and Serum Bilirubin was taken as indication of hepatotoxicity.
The
procedure consists of:
· Group A – Served as
Control and received single daily dose of 1 ml/kg i.p.
of sucrose solution for 4 days along with 1 ml/kg s. c. of olive oil on 2nd
and 3rd days.
· Group B – Also
received single daily dose of 1 ml/kg i. p. aqueous
sucrose solution for 4 days with 2 ml/kg of Carbon tetrachloride by
subcutaneous route dissolved in an equal volume of olive oil on 2nd
and 3rd days.
· Group C– Received
standard drug Liv-52 as a single daily dose of 5 ml/kg of oral route for 4 days
with 2 ml/kg of carbon tetrachloride by subcutaneous route on 2nd
and 3rd days.
· Group D, E, F and G
received single daily dose of 500 mg/kg of extracts by oral route for 4 days
respectively, with 2 ml/kg of carbon tetrachloride by subcutaneous route on 2nd
and 3rd days.
All the rats in all the groups were
sacrificed on 5th day under light anesthetic ether. Blood from each
rat was collected through cardiac puncture under ether anesthesia for
biochemical investigation like SGOT, SGPT, SALP, and serum bilirubin
estimation. Blood was allowed to coagulate at 370C for 30 min and
the serum was separated by centrifugation at 2500 rpm for 10 minutes. The liver of all the experimental animals
were removed and processed immediately for histological investigation.
Estimation of Serum Glutamate Pyruvate Transaminase (SGPT):
SGPT or ALT is located in the cytosol of the liver cell.
During liver cell inflammation, they are released into circulation due
to increased permeability of cell membrane break down of liver cells. Hence, determination of
SGPT as index of the extent of liver damage.
Diagnostic reagent kit was used for
determination of SGPT also called as "Alanine
amino transaminase" (ALT) activity by method of Reitman and Frankel. 17
Estimation of SGOT:
SGOT (AST) is located on the cytosol of liver cell.
In addition, it is also found in the mitochondria. It is also found in many tissue such as
heart, liver, skeletal muscle and kidney which rich source of SGOT in that
order, liver are being the second richest source of SGOT the importance of SGOT
levels in hepatic damage of hepatic cells leads to increased levels of SGOT in
blood serum.
SGOT
Kit is based on Reitman and Frankel's method. 17 SGOT catalyzes the transfer of the amino group of L-aspartate (ASP) to a-ketoglutarate
of the (a-KG) resulting in the formation of oxaloacetate (OAA) and L-glutamate (L-Glu). The oxaloacetate so
formed, is allowed to react with 2, 4-DNPH to form 2, 4 dinitrophenyl
hydrazone derivative which is brown coloured in alkaline medium. The hydrazone
derivative of oxaloacetate similar to pyruvate is considerably more chromogenic
than that of a-KG.
The final colour developed does not obey Beer's
law.
Estimation of SALP /
ALP:
SALP Kit is based on Kind and King Method.18
Alkaline phosphatase (ALP) at an alkaline pH
hydrolyses di Sodium Phenylphosphate
to form phenol. The Phenol formed reacts with 4 -Aminoantipyrine
in the presence of Potassium Ferricyanide, as an
oxidizing agent, to form a red colored complex. The intensity of the colour formed is directly proportional to the activity of
ALP present in the sample.
Table 1: Showing enzymatic SGOT level (IU/
L). (Oxalis corniculata)
Sr. No |
control |
CCl4 |
Standard |
Methanol |
Pet-ether |
Chloroform |
Aqueous |
1 |
47 |
150 |
56 |
92 |
80 |
93 |
57 |
2 |
43 |
153 |
50 |
97 |
65 |
94 |
52 |
3 |
44 |
147 |
63 |
93 |
72 |
82 |
67 |
4 |
44 |
153 |
68 |
103 |
71 |
103 |
61 |
5 |
45 |
159 |
64 |
82 |
65 |
92 |
66 |
6 |
43 |
160 |
61 |
94 |
68 |
97 |
62 |
Mean |
44.5 |
153.7 |
60.33 |
93.5 |
70.17 |
93.5 |
60.83 |
SD |
1.51 |
5.04 |
6.41 |
6.89 |
5.63 |
6.89 |
5.63 |
SE |
0.61 |
2.06 |
2.61 |
2.81 |
2.30 |
2.81 |
2.3 |
F ratio |
309 |
||||||
P value |
- |
- |
P<0.01 |
P<0.05 |
P<0.01 |
P< 0.05 |
P< 0.01 |
P<0.05 is significant
Table 2:
Table 5 showing enzymatic SGPT level (IU/ L). (Oxalis corniculata)
Sr. No |
Control |
CCl4 |
Standard |
Methanol |
Pet-ether |
Chloroform |
Aqueous |
1 |
40 |
133 |
35 |
80 |
53 |
62 |
43 |
2 |
38 |
137 |
39 |
65 |
54 |
63 |
42 |
3 |
39 |
141 |
43 |
72 |
56 |
68 |
47 |
4 |
33 |
143 |
47 |
71 |
58 |
70 |
49 |
5 |
35 |
144 |
45 |
65 |
61 |
77 |
51 |
6 |
36 |
151 |
52 |
68 |
58 |
71 |
54 |
Mean |
36.8 |
141.5 |
43.5 |
70.17 |
56.67 |
68.5 |
47.67 |
SD |
2.63 |
6.18 |
5.99 |
5.63 |
2.94 |
5.54 |
4.63 |
SE |
1.07 |
2.52 |
2.44 |
2.30 |
1.2 |
2.26 |
1.89 |
F
ratio |
379.6 |
||||||
P
value |
- |
- |
P<0.01 |
P<0.05 |
P<0.01 |
P<0.05 |
P<0.01 |
P<0.01
is significant
Table 3: Showing
enzymatic SALP level (IU/ L). (Oxalis corniculata)
Sr. No |
control |
CCl4 |
Standard |
Methanol |
Pet-ether |
Chloroform |
Aqueous |
1 |
27.6 |
81.7 |
41.2 |
74 |
58.1 |
75 |
41.4 |
2 |
24.2 |
92.8 |
45.8 |
85 |
38.2 |
82 |
46.1 |
3 |
25.3 |
100.1 |
44.3 |
89 |
61.8 |
74 |
44.5 |
4 |
24.8 |
81.1 |
42.3 |
75 |
63.7 |
81 |
42.6 |
5 |
25.2 |
93.6 |
45.9 |
81 |
64.8 |
89 |
46.1 |
6 |
25.8 |
89.6 |
41.1 |
82 |
56.7 |
85 |
42.2 |
Mean |
25.4 |
89.82 |
43.43 |
81 |
57.15 |
81 |
43.82 |
SD |
1.16 |
7.36 |
2.19 |
5.76 |
9.77 |
5.76 |
2.04 |
SE |
0.47 |
3.00 |
0.9 |
2.35 |
3.92 |
2.35 |
0.83 |
F
ratio |
11.8 |
||||||
P
value |
- |
- |
P<0.01 |
P<0.05 |
P<0.01 |
P<0.05 |
P<0.01 |
P<0.05 is significant
Table
4: Showing Serum Bilirubin level (IU/ L). (Oxalis corniculata)
Sr, No |
Control |
CCl4 |
Standard |
Methanol |
Pet-ether |
Chloroform |
Aqueous |
|||
1 |
2.31 |
9.3 |
3.22 |
8.6 |
3.6 |
11.02 |
3.3 |
|||
2 |
2.21 |
12.4 |
4.23 |
10.8 |
5.1 |
11 |
4.4 |
|||
3 |
2.11 |
13.8 |
6.11 |
11.3 |
7.0 |
11.5 |
6.7 |
|||
4 |
2.03 |
12.6 |
5.25 |
11.2 |
6.8 |
8.9 |
5.8 |
|||
5 |
2.08 |
13.8 |
6.9 |
12.4 |
7.3 |
12.2 |
7.0 |
|||
6 |
2.03 |
13.2 |
5.8 |
11.8 |
6.1 |
11.5 |
5.9 |
|||
Mean |
2.12 |
12.52 |
5.25 |
11.02 |
5.98 |
11.02 |
5.51 |
|||
SD |
0.11 |
1.68 |
1.33 |
1.30 |
1.40 |
1.30 |
1.41 |
|||
SE |
0.04 |
0.68 |
0.45 |
0.53 |
0.57 |
0.53 |
0.57 |
|||
F
ratio |
53.16 |
|||||||||
P
value |
|
|
P<0.01 |
P<0.05 |
P<0.01 |
P<0.05 |
P<0.01 |
|||
Statistical
analysis: All
the values were expressed as mean ± S.E. Stastical
significance was determined using ANOVA followed by Dunnets
test at a probability level of P ≤ 0.05. (Table No. 1-4; graph 1-4).
RESULT
AND DISCUSSION:
Phytochemical screening of the
solvent ether, chloroform, ethanol extracts that were used in the
pharmacological test has revealed the presence of steroids, glycoside, alkaloids,
tannins and phenolic acids as major chemical
constituents and in aqueous extract shows presence of flavonoids,
phenolic compounds and glycosides.
In our experiments it is observed that the lipid peroxidation levels in the CCl4 group is
increased. This clearly indicates that there is a significant hepatic damage
due to CCl4 and this is further evident from the fact that there is
elevation in the levels of various markers of hepatic damage like SGOT, SGPT
and ALP. Treatment with Oxalis corniculata leaves extract has decreased the levels of lipid peroxidation and the elevated levels of above mentioned
biochemical markers to the near normal levels. It may be concluded that the hepatoprotective effect of Oxalis corniculata is due to
the prevention of the depletion in the tissue GSH levels. Phytochemical
investigation of leaves of Oxalis
corniculata contains phenolic compound and flavanoids which are present in the methanol extract.
Therefore Oxalis corniculata extract possess hepatoprotective
activity (Table No. 1-4; Graph No.1-4).
REFERENCES:
1.
H
E Jaques. Plants
families How to know them.Agrobios
(India) publisher, Jodhpur, 2005; 128.
2.
Vaidyaratnam P. S., Varier’s. Indian Medicinal Plants – A compendium of 500 species, 1994; Vol. IV: 202.
3.
C
N Pandey,B R Raval,Seema Mali, Harshad Salvi. Medicinal
plants of Gujarat state. Gujarat ecological education and research
foundation, Gandinager, 2005; 230.
4.
V.V.Shivrajan and Indira Balachandran. Ayurvedic drugs and their plants sources, Oxford
and IBH publishers, New Delhi, 2004; 113.
5.
Gyanendra
Pandey, Dravyaguna Vijnana, Vol. I: 489.
6.
Kirtikar K. R., Basu B. D., Indian Medicinal Plant,
2nd Ed., Vol. I: 437.
7.
Gaitonde, B.B, S.N. Joglekar,
H.J. Kulkarni and S.D. Nabar.
Anti-inflammatory, analgesic and anti-pyretic activity of an indigenous
medicinal plant Oxalis corniculata Linn., JRIM,
1977; 12, 2, 12-17.
8.
Ayurveda Encyclopedia, 81.
9.
Treas and Evans. Textbook of Pharmacognosy, fifth edition CBS publisher, New Delhi, 478.
10.
Handbook of Medicinal Plants, 247.
11.
Hakim Mohammed Ed., Hamdard
Pharmacopoeia of Eastern Medicine, 22.
12.
Munenge, R.W., Achola, K.J., Mwangi,
J. W. Pharmacological activityof Oxalis corniculata. International
Journal of Pharmacognosy, 1995; 33(3):
247- 9.
13.
Iqbal, M.C.M., S. Meiyalaghan,
K.B. Wijesekara and K.P. Abeyratne.
Antifungal activity from water extracts of some common weeds, Pakistan Journal of Biological sciences2001;
4, 7, 843-845.
14.
Hebbar SS, Harsha VH, Shripathi V, Hegde GR. Ethnomedicine of Dharwad district in Karnataka, India--plants used in oral
health care. J Ethnopharmacol.
2004 Oct; 94(2-3):261-6.
15.
Farnsworth
NR. Biological and phytochemical screening of
plants. J pharm sci; 1966
Mar, 55(3). p. 225-76.
16.
Handa SS.
Sharma A, Hepatoprotective activity of andrographolide from Andrographis
paniculata against CCL4. Indian J Med Res;
1990; 92(8), 92(8). p.137-40
17.
Reitman, S. and Frankel AS. A colorimetric method for the determination of serum
glutamic oxaloacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. ;1967, 26. p.
56.
18.
Kind PR and King EJ. Estimation
of plasma phosphatase by determination of hydrolyzed phenol
with antipyrine. J. Clin.
Pathol; 1954, 7 .p.322
Received on 15.12.2009
Accepted on 10.03.2010
© A&V Publication
all right reserved
Research Journal of Pharmacognosy and Phytochemistry. 2(2): March -April 2010, 136-139